Only the SMZ/TMP-treated Cxcr2-/- mice showed improvement in the BA-disease phenotypes (Fig 1), but clustering the SMZ/TMP-treated Cxcr2-/- mice using all OTUs (Fig 2B) was not successful. The gene discussed is CXCR2; the disease is breast angiosarcoma.